Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2
Closed -$338 551
2026
Q1
$338 Buy
+2
New +$383 ﹤0.01% 572
2025
Q4
Sell
-38
Closed -$7.74K 478
2025
Q3
$7.74K Hold
38
﹤0.01% 377
2025
Q2
$8.39K Hold
38
﹤0.01% 345
2025
Q1
$7.72K Buy
38
+1
+3% +$199 ﹤0.01% 336
2024
Q4
$6.85K Sell
37
-340
-90% -$71.5K ﹤0.01% 336
2024
Q3
$77.7K Buy
377
+1
+0.3% +$193 0.03% 218
2024
Q2
$66.1K Hold
376
0.02% 211
2024
Q1
$64.8K Sell
376
-252
-40% -$38.8K 0.02% 225
2023
Q4
$94.8K Buy
628
+252
+67% +$33.8K 0.04% 160
2023
Q3
$45.4K Buy
376
+340
+944% +$42.3K 0.02% 324
2023
Q2
$4.63K Hold
36
﹤0.01% 315
2023
Q1
$4.3K Hold
36
﹤0.01% 307
2022
Q4
$4.18K Hold
36
﹤0.01% 323
2022
Q3
$4K Hold
36
﹤0.01% 309
2022
Q2
$3K Hold
36
﹤0.01% 280
2022
Q1
$4K Hold
36
﹤0.01% 296
2021
Q4
$4K Buy
+36
New +$3.88K ﹤0.01% 280

Other funds holding CTAS

Operose Advisors's CTAS Position: Q2 2026 in Review

Operose Advisors sold out of Cintas (CTAS) in Q2 2026, closing a stake of 2 shares — an estimated $338 sold.

Operose Advisors first reported a position in CTAS in Q4 2021 and held it in 17 quarters. The position peaked at $94.8K in Q4 2023. 1,426 funds tracked by Wall St. Rank hold CTAS as of Q2 2026.

  • Operose Advisors reported no remaining Cintas position as of Q2 2026 after selling out during the quarter.
  • Operose Advisors sold 2 Cintas shares in Q2 2026, an estimated $338.
  • Operose Advisors first reported a position in Cintas in Q4 2021 and held it in 17 quarters.
  • Operose Advisors's Cintas position peaked at $94.8K in Q4 2023.
  • 1,426 funds tracked by Wall St. Rank held Cintas as of Q2 2026.

Based on Operose Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.